FREQUENTLY ASKED QUESTIONS
text-brand-orange
font-weight-extrabold
site-eyebrow
Your Simtriyo[br-d] questions, answered
font-weight-extrabold
site-h1
0
0
0
What clinical data supports the efficacy of Simtriyo in[br-d]children with ADHD?
font-weight-extrabold
site-h3
16
16
0
In a randomized, double-blind, placebo-controlled study in children (aged 6 through 12), Simtriyo demonstrated statistically significant improvements in hyperactivity/impulsivity and inattention, as measured by the ADHD-RS-5 total score at Week 6.1,2
text-brand-navy
font-weight-medium
size-small
link-underline-red
520px
16
16
0
80
40
0
Has the effect of Simtriyo been studied on associated [br-d]features for children with ADHD?
font-weight-extrabold
site-h3
16
16
0
Executive dysfunction, learning problems, peer relationships, and defiance/aggression were studied in children taking Simtriyo as reported by their parents and caregivers. CGI-S-ADHD, Conners inattention, Conners hyperactivity/impulsivity, executive dysfunction, and defiance/aggression were key secondary endpoints; learning problems and peer relations were exploratory.2,3
text-brand-navy
font-weight-medium
size-small
link-underline-red
520px
16
16
0
80
40
0
Has Simtriyo been studied in children over the long[br-d] term?
font-weight-extrabold
site-h3
16
16
0
In a 52-week open-label extension study, children and adolescents taking Simtriyo showed treatment remained tolerable.4 In this study, the most common adverse reactions included decreased appetite and headache.4
Patients also showed continued improvement in ADHD symptoms.4
Patients also showed continued improvement in ADHD symptoms.4
text-brand-navy
font-weight-medium
size-small
link-underline-red
520px
16
16
0